Postpartum consequences of an overlap of breastfeeding and pregnancy: reduced breast milk intake and growth during early infancy.
(65/731)
OBJECTIVE: Despite cultural pressure to wean when a new pregnancy occurs, some women choose to continue breastfeeding. We determined the effect of an overlap of lactation and late pregnancy on breastfeeding and growth in early infancy. METHODS: We studied 133 Peruvian pregnant women who were > or =18 years of age, had a child <4 years old, and who then had a vaginal birth with a healthy, normal weight infant. Of the 133 women, 68 breastfed during the last trimester of pregnancy (BFP), and 65 had not breastfed during pregnancy (NBFP). On day 2 and at 1-month postpartum, 24-hour intake of breast milk and other liquids was measured. Twice weekly home surveillance documented infant morbidity and dietary intakes. Anthropometry was taken at birth and at 1 month. Maternal anthropometric, health, and socioeconomic status data were collected pre- and postpartum. RESULTS: Pregnant BFP mothers breastfed 5.3 +/- 4.3 times/day. BFP and NBFP infants did not differ in breastfeeding behavior or in colostrum intake on day 2. BFP infants breastfed longer per feed and per 24 hours (35.2 minutes/24 hours) than did NBFP infants; however, 1-month intakes per feed tended to be lower among the BFP infants. After controlling for confounders, BFP infants gained 125 g less than did NBFP infants (about 15% of mean weight gain). A sustained decline would result in a -0.7 z score change in weight-for-age by 6 months. CONCLUSIONS: A lactation-pregnancy overlap had a negative effect on early infant outcomes. Additional studies are needed to determine whether the effect continues past 1 month of age. (+info)
Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection.
(66/731)
Cattle are important reservoirs of enterohemorrhagic Escherichia coli (EHEC) O157:H7 that cause disease in humans. Both dairy and beef cattle are asymptomatically and sporadically infected with EHEC. Our long-term goal is to develop an effective vaccine to prevent cattle from becoming infected and transmitting EHEC O157:H7 to humans. We used passive immunization of neonatal piglets (as a surrogate model) to determine if antibodies against EHEC O157 adhesin (intimin(O157)) inhibit EHEC colonization. Pregnant swine (dams) with serum anti-intimin titers of < or =100 were vaccinated twice with purified intimin(O157) or sham-vaccinated with sterile buffer. Intimin(O157)-specific antibody titers in colostrum and serum of dams were increased after parenteral vaccination with intimin(O157). Neonatal piglets were allowed to suckle vaccinated or sham-vaccinated dams for up to 8 h before they were inoculated with 10(6) CFU of a Shiga toxin-negative (for humane reasons) strain of EHEC O157:H7. Piglets were necropsied at 2 to 10 days after inoculation, and intestinal samples were collected for determination of bacteriological counts and histopathological analysis. Piglets that ingested colostrum containing intimin(O157)-specific antibodies from vaccinated dams, but not those nursing sham-vaccinated dams, were protected from EHEC O157:H7 colonization and intestinal damage. These results establish intimin(O157) as a viable candidate for an EHEC O157:H7 antitransmission vaccine. (+info)
Lactational performance of first-parity transgenic gilts expressing bovine alpha-lactalbumin in their milk.
(67/731)
The goal of this study was to determine whether the presence of the bovine alpha-lactalbumin transgene in first-lactation gilts enhances lactational performance and litter growth. Transgenic and sibling nontransgenic gilts were bred to nontransgenic boars. Litters were standardized to 10 piglets within 24 h of farrowing. Milk production was measured by the weigh-suckle-weigh method on d 3, 6, 9, and 12 of lactation. Bovine alpha-lactalbumin was present in the colostrum and milk of transgenic gilts throughout lactation. The expression of the transgene was associated with alterations in composition of mammary secretions, especially in early lactation. Lactose concentrations were greater (P < 0.05) in mammary secretions of transgenic gilts during the first 12 h postpartum compared with controls. In contrast, total solids concentration in mammary secretions from transgenic gilts were lower (P < 0.05) relative to controls during the first 6 h postpartum. Transgenic gilts produced more milk than controls on d 3, 6, and 9 of lactation (P < 0.01). By d 12, differences in milk production between transgenic and control sows were no longer different. Lactose intake by transgenic-reared litters was greater than lactose intake by control-reared litters on d 6 of lactation (P < 0.05). Total solids intake was significantly greater (P < 0.05) by transgenic-reared litters on d 3 and 6 compared to control-reared litters. The day x genotype interaction on litter weight gain after birth was highly significant (P = 0.011), with transgenic-reared litters gaining weight at a greater rate than control-reared piglets. Expression of the transgene was associated with increased milk production in lactating gilts and increased growth of transgenic-reared piglets. Increased lactose synthesis in response to the presence of the transgene may result in increased milk production in early lactation, leading to increased milk component intake by transgenic litters, and ultimately to increased growth of litters reared by first-parity transgenic gilts. (+info)
The immunological response of the rat to infection with taeniaeformis. IV. Immunoglobulins involved in passive transfer of resistance from mother to offspring.
(68/731)
Weanling rats born of mothers infected with Taenia taeniaeformis were found to be passively protected against homologous challenge. Cross-fostering of normal suckling rats onto immune mothers established that passive transfer occurred via the colostrum and milk. Immunoglobulin fractions containing gammaA from immune colostrum were fed to 12-14-day-old rats for 4 days via stomach tube. Significant passive protection against challenge with T. taeniaeformis was achieved with gammaA from one of three colostrum pools. The effect of colostral gammaA preparations on the infectivity of freshly hatched oncopheres of T. taeniaeformis was measured by the intra-intestinal inoculation of immunoglobulin solutions into isolated gut loops containing hatched eggs of the parasite. gammaA from one of three pools of immune colostrum caused a significant reduction in the number of parasites which reached the liver. This appears to be the first time that protective activity against a helminth infection has been achieved with gammaA. A fraction of immune colostrum containing both 7Sgamma1 and 7Sgamma2 immunoglobulins was found to confer passive protection when inoculated parenterally. In view of the prolonged period of absorption (ca 18 days) of 7S immunoglobulins from the gut by the suckling rat, it seems likely that these antibodies are primarily responsible for the natural passive transfer of protection from mother to young. (+info)
Medium-chain fatty acids but not L-carnitine accelerate the kinetics of [14C]triacylglycerol utilization by colostrum-deprived newborn pigs.
(69/731)
The effect of L-carnitine on in vivo fatty acid utilization was determined using colostrum-deprived newborn piglets fed emulsified triglycerides (TG) composed of [1-14C]octanoate (tri-8:0) or [1-14C]octadecanoate (tri-18:1). A soy protein-based liquid diet devoid of L-carnitine was fed piglets for 1 d to allow development of fatty acid-metabolizing enzymes and intestinal fat digestion and absorption before assessment of in vivo fat utilization. The radiolabeled TG were fed in isoenergetic amounts (97.7 kJ/kg(0.75)), with or without L-carnitine (1 mmol/kg(0.75)) as 30% (v/v) emulsions, using polyoxyethylene sorbitan monooleate as an emulsifier. Expired CO(2) was quantified and specific radioactivity (Bq/micromol) was determined at 20-min intervals over 24 h. The rate (mmol ATP.kg(-0.75).min(-1)) and extent (mol ATP/kg(0.75)) of TG oxidative utilization (i.e., composite of digestion, absorption and oxidation) were calculated from the kinetics of 14CO(2) expiration. The maximal rate and extent of tri-8:0 oxidation were three and fourfold greater than those of tri-18:1, respectively (P < 0.001), and tri-18:1 delayed the time to reach 10 and 50% of maximal oxidation rate by 1.2 and 1.9 h (P < 0.01, respectively), regardless of supplemental carnitine. Collectively, these findings quantify the accelerated oxidation of medium-chain vs. long-chain triglycerides, but fail to support a need for supplemental carnitine to maximize fat oxidation in colostrum-deprived piglets. (+info)
Bacterial contamination of colostrum fed to newborn calves in Quebec dairy herds.
(70/731)
A convenience sample of 234 colostral specimens, collected directly from the nursing bottle immediately prior to the first feeding, was studied. Samples originated from 6 farms and were collected over 24 months. Routine bacteriologic techniques were used to quantify the bacterial load of the colostrum, as well as to identify the bacteria. Overall, at least 1 microorganism was cultured from 221 colostral samples (94.4%). By using the upper tolerance level of 100,000 bacteria/mL, 84 samples (35.9%) were considered contaminated. Staphylococcus spp. (57.7%), gram-negative rods (47.9%), coliforms (44.0%), and Streptococcus uberis (20.5%) were among the most frequently isolated bacteria. The relative risk (RR) of contamination with more than 100,000 bacteria/mL was significantly greater in warm months [RR = 2.55, 95% confidence interval (CI): 1.63 to 4.02] than in cool months and in colostrum offered to male calves (RR = 1.55, 95% CI: 1.09 to 2.20). Bacterial load was also associated with the farm of origin (P < 0.0001). When assessing colostrum management, one should consider bacterial contamination. Multiple factors are likely associated with the degree of contamination, and farm-specific factors may be important. Further studies are necessary to evaluate the impact of bacterial contamination of colostrum on neonatal health. (+info)
IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training.
(71/731)
This study examined the effect of bovine colostrum (Dynamic colostrum) supplementation on blood and saliva variables (study 1) and the absorption of orally administered human recombinant insulin-like growth factor (IGF)-I (rhIGF-I) labeled with 123I (123I-rhIGF-I) (study 2). In study 1, adult male and female athletes were randomly assigned in a double-blind fashion to either an experimental (Dynamic; n = 19) or a control (Placebo; n = 11) group. The former consumed daily 20 g of Dynamic supplement, and the latter 20 g of maltodextrin during a 2-wk training period. After bovine colostrum supplementation, significant increases were noticed in serum IGF-I (P < 0.01) and saliva IgA (P < 0.01) in Dynamic compared with Placebo. In study 2, gel electrophoresis was carried out in 12 adult subjects with serum samples taken 60 min after ingestion of 123I-rhIGF-I and showed peaks at 0.6 and at 40-90 kDa, with the former inducing 96% and the latter 4% of the total radioactivity. It was concluded that a long-term supplementation of bovine colostrum (Dynamic) increases serum IGF-I and saliva IgA concentration in athletes during training. Absorption data show that ingested 123I-rhIGF-I is fragmented in circulation and that no radioactive IGF-I is eluted at the positions of free, or the IGF, binding proteins, giving no support to the absorption of IGF-I from bovine colostrum. (+info)
Modulation of the immune system and the response against pathogens with bovine colostrum concentrates.
(72/731)
The growth, development and health conditions for children living under deprived conditions in developing countries are so adverse that immediate public health measures to reduce morbidity and improve nutrition are urgently needed. Preventing and shortening the course of diarrhoeal episodes, eliminating protozoal colonization, and balancing intestinal microflora would all contribute to these goals. The consumption by humans of part of the colostrum produced when a dairy animal gives birth is an established tradition in many traditional societies. Recent advances in food technology in industrial dairying allow for continuous availability of stabilized bovine colostrum concentrate, both natural and hyperimmunized against specific human pathogens. This is safe for the calves of the producers themselves, for laboratory animals, and generally for humans, with the caveat of the milk-allergic. Moreover, substantial amounts of orally ingested bovine colostrum concentrate survive their passage through the stomach to remain intact and active in the lower reaches of the bowel. Studies in animals, human volunteers and naturally infected humans have demonstrated a therapeutic efficacy of oral bovine colostrum with certain infections. Similarly, attempts to prevent gastrointestinal infections in animals, exposed volunteers and at-risk populations have met with limited success with specific pathogens. It is time to begin to assess the feasibility and potential effectiveness and efficiency of employing seasonal or chronic bovine colostrum feeding in populations of deprived infantile populations to reduce the rates of recurrent gastroenteritis and decrease immunostimulation to improve vitality and nutritional status in early life. (+info)